As US Slows Down, Torrent Aims For Germany, Brazil
Indian Field Force Downsized
A lack of new launches and price erosion caused a sharp dip in Torrent’s Q3 US revenues, but the company plans to ramp up its presence in Brazil and Germany to build momentum. Meanwhile, the field force in India has been downsized with an aim to defocus on older brands.
You may also be interested in...
Two groups have issued largely complementary testing methods for measuring nitrosamine impurities in drugs, and the differences that do exist are “insignificant,” EDQM official advises. The two are working to further harmonize testing standards, given the global scope of the nitrosamine scare.
Torrent restarts sale of losartan in the US, exercising caution to ensure the API sourced is “impurity free.” Timely resolution of compliance deviations at the firm’s Indian sites is also critical for growth momentum in the US.
From a STING agonist to a SOS1 inhibitor, Lupin listed oncology candidates from the preclinical stage to those in IND-enabling studies during the recently concluded J.P. Morgan conference. Meanwhile, the newly spun-off oncology subsidiary awaits partners.